Ohcanbohtosat - Carroll, Miles

Development of vaccines against Crimean-Congo haemorrhagic fever virus Dahkki Dowall, Stuart D., Carroll, Miles W., Hewson, Roger

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Viral Evasion of the Complement System and Its Importance for Vaccines and Therapeutics Dahkki Mellors, Jack, Tipton, Tom, Longet, Stephanie, Carroll, Miles

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Ebolavirus: Comparison of Survivor Immunology and Animal Models in the Search for a Correlate of Protection Dahkki Longet, Stephanie, Mellors, Jack, Carroll, Miles W., Tipton, Tom

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Identification of a major histocompatibility complex class I-restricted T-cell epitope in the tumour-associated antigen, 5T4 Dahkki Redchenko, Irina, Harrop, Richard, Ryan, Matthew G, Hawkins, Robert E, Carroll, Miles W

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Herd Immunity to Ebolaviruses Is Not a Realistic Target for Current Vaccination Strategies Dahkki Masterson, Stuart G., Lobel, Leslie, Carroll, Miles W., Wass, Mark N., Michaelis, Martin

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Filovirus Neutralising Antibodies: Mechanisms of Action and Therapeutic Application Dahkki Hargreaves, Alexander, Brady, Caolann, Mellors, Jack, Tipton, Tom, Carroll, Miles W., Longet, Stephanie

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Vaccine-Associated Enhanced Disease and Pathogenic Human Coronaviruses Dahkki Gartlan, Cillian, Tipton, Tom, Salguero, Francisco J., Sattentau, Quentin, Gorringe, Andrew, Carroll, Miles W.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Quantification of Type I Interferon Inhibition by Viral Proteins: Ebola Virus as a Case Study Dahkki Locke, Macauley, Lythe, Grant, López-García, Martín, Muñoz-Fontela, César, Carroll, Miles, Molina-París, Carmen

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a Murine tumor model Dahkki Carroll, Miles W., Overwijk, Willem W., Chamberlain, Ronald S., Rosenberg, Steven A., Moss, Bernard, Restifo, Nicholas P.

Viečča ollesdeavstta Viečča ollesdeavstta

Construction and Characterization of a Triple-Recombinant Vaccinia Virus Encoding B7-1, Interleukin 12, and a Model Tumor Antigen Dahkki Carroll, Miles W., Overwijk, Willem W., Surman, Deborah R., Tsung, Kangla, Moss, Bernard, Restifo, Nicholas P.

Viečča ollesdeavstta Viečča ollesdeavstta

The Ministry of Health and Sanitation, Sierra Leone  – Public Health England (MOHS-PHE) Ebola Biobank Dahkki Hannigan, Bernie, Whitworth, Jimmy, Carroll, Miles, Roberts, Allen, Bruce, Christine, Samba, Thomas, Sahr, Foday, Coates, Elizabeth

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

A Novel Vaccine against Crimean-Congo Haemorrhagic Fever Protects 100% of Animals against Lethal Challenge in a Mouse Model Dahkki Buttigieg, Karen R., Dowall, Stuart D., Findlay-Wilson, Stephen, Miloszewska, Aleksandra, Rayner, Emma, Hewson, Roger, Carroll, Miles W.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Re-emergence of Lloviu virus in Miniopterus schreibersii bats, Hungary, 2016 Dahkki Kemenesi, Gábor, Kurucz, Kornélia, Dallos, Bianka, Zana, Brigitta, Földes, Fanni, Boldogh, Sándor, Görföl, Tamás, Carroll, Miles W, Jakab, Ferenc

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Metagenomic identification of a new sarbecovirus from horseshoe bats in Europe Dahkki Crook, Jack M., Murphy, Ivana, Carter, Daniel P., Pullan, Steven T., Carroll, Miles, Vipond, Richard, Cunningham, Andrew A., Bell, Diana

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing Dahkki Salam, Alex P., Duvignaud, Alexandre, Jaspard, Marie, Malvy, Denis, Carroll, Miles, Tarning, Joel, Olliaro, Piero L., Horby, Peter W.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Comparative Efficacy of Recombinant Modified Vaccinia Virus Ankara Expressing Simian Immunodeficiency Virus (SIV) Gag-Pol and/or Env in Macaques Challenged with Pathogenic SIV Dahkki Ourmanov, Ilnour, Brown, Charles R., Moss, Bernard, Carroll, Miles, Wyatt, Linda, Pletneva, Liuobov, Goldstein, Simoy, Venzon, David, Hirsch, Vanessa M.

Viečča ollesdeavstta Viečča ollesdeavstta

Characterization of the murine 5T4 oncofoetal antigen: a target for immunotherapy in cancer. Dahkki Woods, Andrew M, Wang, Who W, Shaw, David M, Ward, Christopher M, Carroll, Miles W, Rees, Buddug R, Stern, Peter L

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

IL-12 Is an Effective Adjuvant to Recombinant Vaccinia Virus-Based Tumor Vaccines: Enhancement by Simultaneous B7-1 Expression Dahkki Rao, Jay B., Chamberlain, Ronald S., Bronte, Vincenzo, Carroll, Miles W., Irvine, Kari R., Moss, Bernard, Rosenberg, Steven A., Restifo, Nicholas P.

Viečča ollesdeavstta Viečča ollesdeavstta

Protective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responses Dahkki Dowall, Stuart D., Graham, Victoria A., Rayner, Emma, Hunter, Laura, Watson, Robert, Taylor, Irene, Rule, Antony, Carroll, Miles W., Hewson, Roger

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Detection of Viral Pathogens With Multiplex Nanopore MinION Sequencing: Be Careful With Cross-Talk Dahkki Xu, Yifei, Lewandowski, Kuiama, Lumley, Sheila, Pullan, Steven, Vipond, Richard, Carroll, Miles, Foster, Dona, Matthews, Philippa C., Peto, Timothy, Crook, Derrick

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta